Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 255

1.

PERL in Diabetes Study: A Randomized Double-Blinded Trial of Allopurinol-Rationale, Design, and Baseline Data.

Afkarian M, Polsky S, Parsa A, Aronson R, Caramori ML, Cherney DZ, Crandall JP, de Boer IH, Elliott TG, Galecki AT, Goldfine AB, Haw JS, Hirsch IB, Karger AB, Lingvay I, Maahs DM, McGill JB, Molitch ME, Perkins BA, Pop-Busui R, Pragnell M, Rosas SE, Rossing P, Senior P, Sigal RJ, Spino C, Tuttle KR, Umpierrez GE, Wallia A, Weinstock RS, Wu C, Mauer M, Doria A; PERL Study Group.

Diabetes Care. 2019 Jun 11. pii: dc190342. doi: 10.2337/dc19-0342. [Epub ahead of print]

PMID:
31186299
2.

Early Glomerular Hyperfiltration and Long-Term Kidney Outcomes in Type 1 Diabetes: The DCCT/EDIC Experience.

Molitch ME, Gao X, Bebu I, de Boer IH, Lachin J, Paterson A, Perkins B, Saenger AK, Steffes M, Zinman B; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group.

Clin J Am Soc Nephrol. 2019 Jun 7;14(6):854-861. doi: 10.2215/CJN.14831218. Epub 2019 May 23.

PMID:
31123181
3.

Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline.

LeRoith D, Biessels GJ, Braithwaite SS, Casanueva FF, Draznin B, Halter JB, Hirsch IB, McDonnell ME, Molitch ME, Murad MH, Sinclair AJ.

J Clin Endocrinol Metab. 2019 May 1;104(5):1520-1574. doi: 10.1210/jc.2019-00198.

PMID:
30903688
4.

Development of a Predictive Model for Hyperglycemia in Nondiabetic Recipients After Liver Transplantation.

Zelada H, VanWagner LB, Pollack T, Higginbotham D, Zhao L, Yang A, Molitch ME, Wallia A.

Transplant Direct. 2018 Sep 20;4(10):e393. doi: 10.1097/TXD.0000000000000830. eCollection 2018 Oct.

5.

Hyperglycemia in the Posttransplant Period: NODAT vs Posttransplant Diabetes Mellitus.

Gupta S, Pollack T, Fulkerson C, Schmidt K, Oakes DJ, Molitch ME, Wallia A.

J Endocr Soc. 2018 Oct 15;2(11):1314-1319. doi: 10.1210/js.2018-00227. eCollection 2018 Nov 1.

6.

Effect of testosterone replacement on measures of mobility in older men with mobility limitation and low testosterone concentrations: secondary analyses of the Testosterone Trials.

Bhasin S, Ellenberg SS, Storer TW, Basaria S, Pahor M, Stephens-Shields AJ, Cauley JA, Ensrud KE, Farrar JT, Cella D, Matsumoto AM, Cunningham GR, Swerdloff RS, Wang C, Lewis CE, Molitch ME, Barrett-Connor E, Crandall JP, Hou X, Preston P, Cifelli D, Snyder PJ, Gill TM.

Lancet Diabetes Endocrinol. 2018 Nov;6(11):879-890. doi: 10.1016/S2213-8587(18)30171-2.

PMID:
30366567
7.

Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney disease.

Chertow GM, Appel GB, Block GA, Chin MP, Coyne DW, Goldsberry A, Kalantar-Zadeh K, Meyer CJ, Molitch ME, Pergola PE, Raskin P, Silva AL, Spinowitz B, Sprague SM, Rossing P.

J Diabetes Complications. 2018 Dec;32(12):1113-1117. doi: 10.1016/j.jdiacomp.2018.09.005. Epub 2018 Sep 13.

8.

New Onset Diabetes After Transplant: Data from the Folic Acid for Vascular Outcome Reduction in Transplantation Trial.

Wallia A, Molitch ME.

Am J Med. 2018 Aug;131(8):e347. doi: 10.1016/j.amjmed.2018.03.005. No abstract available.

PMID:
30121094
9.

Validation of data from electronic data warehouse in diabetic ketoacidosis: Caution is needed.

VanderWeele J, Pollack T, Oakes DJ, Smyrniotis C, Illuri V, Vellanki P, O'Leary K, Holl J, Aleppo G, Molitch ME, Wallia A.

J Diabetes Complications. 2018 Jul;32(7):650-654. doi: 10.1016/j.jdiacomp.2018.05.004. Epub 2018 May 8.

PMID:
29903409
10.

Screening for comorbid conditions in patients enrolled in the SODA registry: a 2-year observational analysis.

Woodmansee WW, Gordon MB, Molitch ME, Ioachimescu AG, Carver DW, Mirakhur B, Cox D, Salvatori R.

Endocrine. 2018 Jul;61(1):105-117. doi: 10.1007/s12020-018-1615-3. Epub 2018 May 16.

11.

Lessons From the Testosterone Trials.

Snyder PJ, Bhasin S, Cunningham GR, Matsumoto AM, Stephens-Shields AJ, Cauley JA, Gill TM, Barrett-Connor E, Swerdloff RS, Wang C, Ensrud KE, Lewis CE, Farrar JT, Cella D, Rosen RC, Pahor M, Crandall JP, Molitch ME, Resnick SM, Budoff M, Mohler ER 3rd, Wenger NK, Cohen HJ, Schrier S, Keaveny TM, Kopperdahl D, Lee D, Cifelli D, Ellenberg SS.

Endocr Rev. 2018 Jun 1;39(3):369-386. doi: 10.1210/er.2017-00234.

12.

Management of nonfunctioning pituitary adenomas (NFAs): observation.

Huang W, Molitch ME.

Pituitary. 2018 Apr;21(2):162-167. doi: 10.1007/s11102-017-0856-0. Review.

PMID:
29280025
13.

Glycemic Control Assessment in the Dialysis Patient: Is Glycated Albumin the Answer?

Molitch ME.

Am J Nephrol. 2018;47(1):18-20. doi: 10.1159/000485844. Epub 2017 Dec 22. No abstract available.

14.

The Effect of Testosterone on Cardiovascular Biomarkers in the Testosterone Trials.

Mohler ER 3rd, Ellenberg SS, Lewis CE, Wenger NK, Budoff MJ, Lewis MR, Barrett-Connor E, Swerdloff RS, Stephens-Shields A, Bhasin S, Cauley JA, Crandall JP, Cunningham GR, Ensrud KE, Gill TM, Matsumoto AM, Molitch ME, Pahor M, Preston PE, Hou X, Cifelli D, Snyder PJ.

J Clin Endocrinol Metab. 2018 Feb 1;103(2):681-688. doi: 10.1210/jc.2017-02243.

15.

Biomarkers of tubulointerstitial damage and function in type 1 diabetes.

de Boer IH, Gao X, Bebu I, Hoofnagle AN, Lachin JM, Paterson A, Perkins BA, Saenger AK, Steffes MW, Zinman B, Molitch ME.

BMJ Open Diabetes Res Care. 2017 Nov 14;5(1):e000461. doi: 10.1136/bmjdrc-2017-000461. eCollection 2017.

16.

Excellence in the treatment of patients with pituitary tumors.

Molitch ME, Findling JW, Clemmons DR.

Pituitary. 2018 Feb;21(1):107. doi: 10.1007/s11102-017-0848-0. No abstract available.

PMID:
29124563
17.

Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study.

Aroda VR, Knowler WC, Crandall JP, Perreault L, Edelstein SL, Jeffries SL, Molitch ME, Pi-Sunyer X, Darwin C, Heckman-Stoddard BM, Temprosa M, Kahn SE, Nathan DM; Diabetes Prevention Program Research Group.

Diabetologia. 2017 Sep;60(9):1601-1611. doi: 10.1007/s00125-017-4361-9. Epub 2017 Aug 2. Review.

18.

A multicenter, observational study of lanreotide depot/autogel (LAN) in patients with acromegaly in the United States: 2-year experience from the SODA registry.

Salvatori R, Gordon MB, Woodmansee WW, Ioachimescu AG, Carver DW, Mirakhur B, Cox D, Molitch ME.

Pituitary. 2017 Dec;20(6):605-618. doi: 10.1007/s11102-017-0821-y.

PMID:
28741071
19.

Testosterone Treatment and Cognitive Function in Older Men With Low Testosterone and Age-Associated Memory Impairment.

Resnick SM, Matsumoto AM, Stephens-Shields AJ, Ellenberg SS, Gill TM, Shumaker SA, Pleasants DD, Barrett-Connor E, Bhasin S, Cauley JA, Cella D, Crandall JP, Cunningham GR, Ensrud KE, Farrar JT, Lewis CE, Molitch ME, Pahor M, Swerdloff RS, Cifelli D, Anton S, Basaria S, Diem SJ, Wang C, Hou X, Snyder PJ.

JAMA. 2017 Feb 21;317(7):717-727. doi: 10.1001/jama.2016.21044.

20.

Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone.

Budoff MJ, Ellenberg SS, Lewis CE, Mohler ER 3rd, Wenger NK, Bhasin S, Barrett-Connor E, Swerdloff RS, Stephens-Shields A, Cauley JA, Crandall JP, Cunningham GR, Ensrud KE, Gill TM, Matsumoto AM, Molitch ME, Nakanishi R, Nezarat N, Matsumoto S, Hou X, Basaria S, Diem SJ, Wang C, Cifelli D, Snyder PJ.

JAMA. 2017 Feb 21;317(7):708-716. doi: 10.1001/jama.2016.21043.

21.

Association of Testosterone Levels With Anemia in Older Men: A Controlled Clinical Trial.

Roy CN, Snyder PJ, Stephens-Shields AJ, Artz AS, Bhasin S, Cohen HJ, Farrar JT, Gill TM, Zeldow B, Cella D, Barrett-Connor E, Cauley JA, Crandall JP, Cunningham GR, Ensrud KE, Lewis CE, Matsumoto AM, Molitch ME, Pahor M, Swerdloff RS, Cifelli D, Hou X, Resnick SM, Walston JD, Anton S, Basaria S, Diem SJ, Wang C, Schrier SL, Ellenberg SS.

JAMA Intern Med. 2017 Apr 1;177(4):480-490. doi: 10.1001/jamainternmed.2016.9540.

22.

Diagnosis and Treatment of Pituitary Adenomas: A Review.

Molitch ME.

JAMA. 2017 Feb 7;317(5):516-524. doi: 10.1001/jama.2016.19699. Review.

PMID:
28170483
23.

Glycemic Control Reduces Infections in Post-Liver Transplant Patients: Results of a Prospective, Randomized Study.

Wallia A, Schmidt K, Oakes DJ, Pollack T, Welsh N, Kling-Colson S, Gupta S, Fulkerson C, Aleppo G, Parikh N, Levitsky J, Norvell JP, Rademaker A, Molitch ME.

J Clin Endocrinol Metab. 2017 Feb 1;102(2):451-459. doi: 10.1210/jc.2016-3279.

24.

Albuminuria Changes and Cardiovascular and Renal Outcomes in Type 1 Diabetes: The DCCT/EDIC Study.

de Boer IH, Gao X, Cleary PA, Bebu I, Lachin JM, Molitch ME, Orchard T, Paterson AD, Perkins BA, Steffes MW, Zinman B; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group.

Clin J Am Soc Nephrol. 2016 Nov 7;11(11):1969-1977. Epub 2016 Oct 24.

25.

Pituitary tumors in MEN1: do not be misled by borderline elevated prolactin levels.

Livshits A, Kravarusic J, Chuang E, Molitch ME.

Pituitary. 2016 Dec;19(6):601-604.

PMID:
27600151
26.

EVALUATION OF OUTCOMES AND COMPLICATIONS IN PATIENTS WHO EXPERIENCE HYPOGLYCEMIA AFTER CARDIAC SURGERY.

Lowden E, Schmidt K, Mulla I, Andrei AC, Cashy J, Oakes DJ, Aleppo G, Grady KL, Wallia A, Molitch ME.

Endocr Pract. 2017 Jan;23(1):46-55. doi: 10.4158/EP161427.OR. Epub 2016 Sep 28.

PMID:
27682356
27.

An Evaluation of Recurrent Diabetic Ketoacidosis, Fragmentation of Care, and Mortality Across Chicago, Illinois.

Mays JA, Jackson KL, Derby TA, Behrens JJ, Goel S, Molitch ME, Kho AN, Wallia A.

Diabetes Care. 2016 Oct;39(10):1671-6. doi: 10.2337/dc16-0668. Epub 2016 Jul 15.

PMID:
27422579
28.

Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels.

Cunningham GR, Stephens-Shields AJ, Rosen RC, Wang C, Bhasin S, Matsumoto AM, Parsons JK, Gill TM, Molitch ME, Farrar JT, Cella D, Barrett-Connor E, Cauley JA, Cifelli D, Crandall JP, Ensrud KE, Gallagher L, Zeldow B, Lewis CE, Pahor M, Swerdloff RS, Hou X, Anton S, Basaria S, Diem SJ, Tabatabaie V, Ellenberg SS, Snyder PJ.

J Clin Endocrinol Metab. 2016 Aug;101(8):3096-104. doi: 10.1210/jc.2016-1645. Epub 2016 Jun 29.

29.

Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? Yes, They Should Be Relaxed! What's the Fuss?

Bakris GL, Molitch ME.

Diabetes Care. 2016 Jul;39(7):1287-91. doi: 10.2337/dc15-2534.

PMID:
27330130
30.

INPATIENT HYPOGLYCEMIC EVENTS IN A COMPARATIVE EFFECTIVENESS TRIAL FOR GLYCEMIC CONTROL IN A HIGH-RISK POPULATION.

Welsh N, Derby T, Gupta S, Fulkerson C, Oakes DJ, Schmidt K, Parikh ND, Norvell JP, Levitsky J, Rademaker A, Molitch ME, Wallia A.

Endocr Pract. 2016 Sep;22(9):1040-7. doi: 10.4158/EP151166.OR. Epub 2016 Apr 28.

PMID:
27124695
31.

Diabetes Care After Transplant: Definitions, Risk Factors, and Clinical Management.

Wallia A, Illuri V, Molitch ME.

Med Clin North Am. 2016 May;100(3):535-50. doi: 10.1016/j.mcna.2016.01.005. Epub 2016 Mar 18. Review.

PMID:
27095644
32.

Effects of Testosterone Treatment in Older Men.

Snyder PJ, Bhasin S, Cunningham GR, Matsumoto AM, Stephens-Shields AJ, Cauley JA, Gill TM, Barrett-Connor E, Swerdloff RS, Wang C, Ensrud KE, Lewis CE, Farrar JT, Cella D, Rosen RC, Pahor M, Crandall JP, Molitch ME, Cifelli D, Dougar D, Fluharty L, Resnick SM, Storer TW, Anton S, Basaria S, Diem SJ, Hou X, Mohler ER 3rd, Parsons JK, Wenger NK, Zeldow B, Landis JR, Ellenberg SS; Testosterone Trials Investigators.

N Engl J Med. 2016 Feb 18;374(7):611-24. doi: 10.1056/NEJMoa1506119.

33.

Relationship Between Hyperglycemia and Heart Transplant Rejection.

Mateo R, Gupta S, Wallia A, Cameron C, Schmidt K, Oakes DJ, Aleppo G, Andrei AC, Wilcox JE, Grady K, Gordon R, Molitch ME.

Transplant Proc. 2015 Nov;47(9):2727-31. doi: 10.1016/j.transproceed.2015.09.063.

PMID:
26680082
34.

What Does This Retina Examination Show?

Huang W, Mirza RG, Molitch ME.

JAMA. 2015 Dec 15;314(23):2555-6. doi: 10.1001/jama.2015.9162. No abstract available.

PMID:
26670973
35.

Osilodrostat, a potent oral 11╬▓-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing's disease.

Fleseriu M, Pivonello R, Young J, Hamrahian AH, Molitch ME, Shimizu C, Tanaka T, Shimatsu A, White T, Hilliard A, Tian C, Sauter N, Biller BM, Bertagna X.

Pituitary. 2016 Apr;19(2):138-48. doi: 10.1007/s11102-015-0692-z.

36.

Letter to the Editor: Parathyroidectomy Halts the Deterioration of Renal Function in Primary Hyperparathyroidism.

Molitch ME.

J Clin Endocrinol Metab. 2015 Oct;100(10):L98. doi: 10.1210/jc.2015-3219. No abstract available.

PMID:
26439162
37.

Diabetic Kidney Disease: Much Progress, But Still More to Do.

Molitch ME.

Diabetes Spectr. 2015 Aug;28(3):154-6. doi: 10.2337/diaspect.28.3.154. No abstract available.

38.

Enlarged thymus in a patient with dyspnea and weight loss.

Huang W, Molitch ME.

JAMA. 2015 Jun 2;313(21):2174-5. doi: 10.1001/jama.2015.2713. No abstract available.

PMID:
26034958
39.

Management of diabetes mellitus in patients with chronic kidney disease.

Hahr AJ, Molitch ME.

Clin Diabetes Endocrinol. 2015 Jun 4;1:2. doi: 10.1186/s40842-015-0001-9. eCollection 2015.

40.

Prolactinoma Management.

Molitch ME, Drummond J, Korbonits M.

In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Perreault L, Purnell J, Rebar R, Singer F, Trence DL, Vinik A, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. No abstract available.
2018 Sep 30.

41.

Endocrine Disorders of Pregnancy.

Molitch ME, Purdy LP.

In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Perreault L, Purnell J, Rebar R, Singer F, Trence DL, Vinik A, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2002 May 1.

42.

Recruitment and Screening for the Testosterone Trials.

Cauley JA, Fluharty L, Ellenberg SS, Gill TM, Ensrud KE, Barrett-Connor E, Cifelli D, Cunningham GR, Matsumoto AM, Bhasin S, Pahor M, Farrar JT, Cella D, Rosen RC, Resnick SM, Swerdloff RS, Lewis CE, Molitch ME, Crandall JP, Stephens-Shields AJ, Strorer TW, Wang C, Anton S, Basaria S, Diem S, Tabatabaie V, Dougar D, Hou X, Snyder PJ.

J Gerontol A Biol Sci Med Sci. 2015 Sep;70(9):1105-11. doi: 10.1093/gerona/glv031. Epub 2015 Apr 15.

43.

Endocrinology in pregnancy: management of the pregnant patient with a prolactinoma.

Molitch ME.

Eur J Endocrinol. 2015 May;172(5):R205-13. doi: 10.1530/EJE-14-0848. Review.

PMID:
25805896
44.

Cross-Disciplinary Biomarkers Research: Lessons Learned by the CKD Biomarkers Consortium.

Hsu CY, Ballard S, Batlle D, Bonventre JV, B├Âttinger EP, Feldman HI, Klein JB, Coresh J, Eckfeldt JH, Inker LA, Kimmel PL, Kusek JW, Liu KD, Mauer M, Mifflin TE, Molitch ME, Nelsestuen GL, Rebholz CM, Rovin BH, Sabbisetti VS, Van Eyk JE, Vasan RS, Waikar SS, Whitehead KM, Nelson RG; CKD Biomarkers Consortium.

Clin J Am Soc Nephrol. 2015 May 7;10(5):894-902. doi: 10.2215/CJN.11541114. Epub 2015 Mar 4. Review.

45.

Association of sex hormones with sexual function, vitality, and physical function of symptomatic older men with low testosterone levels at baseline in the testosterone trials.

Cunningham GR, Stephens-Shields AJ, Rosen RC, Wang C, Ellenberg SS, Matsumoto AM, Bhasin S, Molitch ME, Farrar JT, Cella D, Barrett-Connor E, Cauley JA, Cifelli D, Crandall JP, Ensrud KE, Fluharty L, Gill TM, Lewis CE, Pahor M, Resnick SM, Storer TW, Swerdloff RS, Anton S, Basaria S, Diem S, Tabatabaie V, Hou X, Snyder PJ.

J Clin Endocrinol Metab. 2015 Mar;100(3):1146-55. doi: 10.1210/jc.2014-3818. Epub 2014 Dec 30.

46.

Current approaches to the pharmacological management of Cushing's disease.

Molitch ME.

Mol Cell Endocrinol. 2015 Jun 15;408:185-9. doi: 10.1016/j.mce.2014.09.021. Epub 2014 Oct 29. Review.

PMID:
25450859
47.

The authors reply.

de Zeeuw D, Molitch ME.

Kidney Int. 2014 Dec;86(6):1270. doi: 10.1038/ki.2014.263. No abstract available.

48.

Acromegaly: an endocrine society clinical practice guideline.

Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, Wass JA; Endocrine Society.

J Clin Endocrinol Metab. 2014 Nov;99(11):3933-51. doi: 10.1210/jc.2014-2700. Epub 2014 Oct 30.

PMID:
25356808
49.

Diabetic kidney disease: a report from an ADA Consensus Conference.

Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, Neumiller JJ, Patel UD, Ratner RE, Whaley-Connell AT, Molitch ME.

Am J Kidney Dis. 2014 Oct;64(4):510-33. doi: 10.1053/j.ajkd.2014.08.001.

PMID:
25257325
50.

Diabetic kidney disease: a report from an ADA Consensus Conference.

Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, Neumiller JJ, Patel UD, Ratner RE, Whaley-Connell AT, Molitch ME.

Diabetes Care. 2014 Oct;37(10):2864-83. doi: 10.2337/dc14-1296.

Supplemental Content

Loading ...
Support Center